Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 22 for “"Chemo-sensitivity"”.
-
ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
Chemotherapy is standard of care for treating cancer and controlling tumor progression. However, chemotherapeutic drugs can display a multitude of side effects. An ongoing challenge is to find improved methods of identifying and classifying groups of tumors with differing biological behaviors or …
-
Omega-3 Fatty Acids as Therapeutic Options for the Treatment of B-cell Chronic Lymphocytic Leukemia
… CLL or enhance the effects of actively used chemo-therapeutic drugs in patients who require therapy would be clinically beneficial. In our studies, we evaluated the use of omega-3 (n-3) fatty acids as therapeutic options for CLL utilizing both a clinical supplementation model (FWA #00002704) …
-
On a stochastic particle model of the Keller-Segel equation and its macroscopic limit
… the two-dimensional Keller-Segel equation for chemo- taxis from a stochastic system of N interacting particles in the situation in which bounded solutions are guaranteed to exist globally in time, that is in the case of subcritical chemo- sensitivity
-
Pharmacogenomics of Chemotherapeutic Agents: Carboplatin and Paclitaxel
… drugs are currently used as standard-of-care chemotherapy, often in combination with taxanes, for various cancers including lung cancer- the most common malignancy, and ovarian cancer- the most lethal gynecological malignancy. However, the overall response rate of carboplatin/paclitaxel-based …
-
Targeting Mitochondrial manganese superoxide dismutase to improve treatment of Breast carcinoma
… an accumulation of mitochondria ROS and enhances chemo-sensitivity. Furthermore, we showed that PPAR? is under epigenetic regulation and that treatment with histone deacetyase inhibitors (HDACi) increases PPAR? acetylation status, activity and expression levels. Therefore, we propose a combination …
-
Enhancing The Efficacy Of Thymidylate Synthase Inhibitors By Genetic Modulation Or Pharmacological Inhibition Of Bone Marrow Derived Cells In The Tumor Stroma
… affect the efficacy of tumor-directed chemotherapies. Tumors are now considered as complex organ consisting of both cancerous and noncancerous cells interacting with each other within the tumor microenvironment to promote malignancy. For decades, 5- fluorouracil (5-FU), an inhibitor of …
-
Autophagy in siRNA-mediated PRKAR1A knockdown canine osteosarcoma cells
… be due to the ability of OSA cells to resist chemotherapy-induced cell death by entering autophagy. Autophagy, or “self-eating”, is an evolutionarily conserved intracellular catabolic process which plays an important role in adaptation to environmental changes and maintenance of cellular …
-
A microfluidic platform for functional assays on tumour biopsy-derived spheroids for precision medicine
… and molecular diagnostics, as well as functional chemo-sensitivity screening assays. In recent years, the use and development of physiologically relevant patient-derived 3D in vitro cancer models has increased, since 3D ex vivo and in vitro models can replicate many aspects of the tumour …
-
Long Non-coding RNA PVT1 – An Exploratory Study in Ovarian and Endometrial Cancer
… including doxorubicin metabolism, which impacts chemo sensitivity in ovarian cancer. We further investigated the role of PVT1 DNA alterations and RNA expression in endometrial cancer. We find that PVT1 has predictive value for survival and potentially treatment response. High PVT1 RNA expression …
-
Functional consequences of transmembrane protein 30A (TMEM30A) inactivating mutations in diffuse large B-cell lymphoma
… to nutrient deprived conditions and increased chemo-sensitivity observed in DLBCL cells with TMEM30A inactivation may allow the identification of novel therapeutic approaches for the treatment of B-cell lymphomas.
-
Molecular Interplay of Chromatin Remodeling Factor BRG1 and Transcription Factor STAT3 Regulates Stemness, Chemosensitivity and Tumorigenicity of Glioma Tumor Initiating Cells
… that BRG1 plays a critical role in the chemo sensitivity of the GICs.
-
The evaluation of the IGF-1R as a proposed biomarker for DNA damaging cancer therapies
… survival. IGF-1R inhibition enhances radio- and chemo-sensitivity, potentially influencing DNA damage response, whilst IGF1R SNP rs4966013 has been identified as the SNP in the p53 stress response network most significantly associated with differences in chemosensitivity.</p> <p><u>Aims:</u> 1. …
-
Disulfiram (Antabuse) acts as a potent chemo-radio sensitizer and abolishes stem cells in HNSCC cell lines in vitro
… resistance of cancer stem cells (CSCs) to radio-chemotherapy. ALDH (Aldehyde Dehydrogenase) has been used as a marker to identify CSCs in several tumors including HNSCC. Disulfiram (DSF) is a pan-ALDH inhibitor, which has been found to have remarkable anti-cancer activity. Moreover, DSF is a …
-
From a Road Less Travelled to a Worn Path: Three-Dimensional Tumour Models for Cancer Research and Therapeutics
… are not reliable tools for investigating chemo sensitivity of anti-cancer drug candidates.Therefore, the emerging miniaturized 3D tumour models in vitro are better representatives of thehuman tumour growing in the in vivo microenvironment. We have established a complex 3D humantumour …
-
Does the IGF axis influence EMT to play a role in bladder cancer progression?
… including the development of resistance to chemotherapy. Epithelial-to-mesenchymal transition (EMT) and high insulin-like growth factor (IGF)-activity have been reported to facilitate tumour development in many cancer types including bladder. Insulin-like growth factor binding protein 2 …
-
Proteomic Investigation of Endocrine Therapy Resistance in Breast Cancer Investigating the Molecular Mechanisms for SERM Resistant Cell Lines Using SILAC-Based Proteomic Approach
… to endocrine treatment. Method: In vitro chemo-sensitivity (IC50) was determined for MCF7, T47D, MDA-MB-231, MDA-MB-468, MDA-MB-453, BT-20 and MCF-10A breast cell lines using four endocrine-based therapeutic agents (Tamoxifen, 4-Hydroxytamoxifen OHT, Raloxifene, Anastrozole) to select …
-
The development of 3D colorectal cancer models to test cancer therapies
… for advanced or metastatic colorectal cancer is chemotherapy. This can take the form of mono-therapy with Capcitebine or oxaliplatin, in combination with 5-fluorocil (5-FU) and folinic acid. However, acquired drug resistance is a major issue and this can result in a decrease in therapeutic …
-
Mechanisms of repression of the transcription factor NRF2 by KEAP1- and B-TrCP-dependent ubiquitin ligases and how the dysregulation of NRF2 contributes to lung cancer progression
… oxidative conditions and enhancing resistance to chemotherapeutic drugs; many groups have focussed on understanding KEAP1-independent forms of NRF2 regulation.<br/><br/>It is now widely accepted that GSK-3 phosphorylation of the Neh6 domain of NRF2 is fundamental for SCFβ-TrCP-mediated degradation …
-
The intermediate filament synemin promotes non-homologous end joining in an ATM-dependent manner
… matrix is a well-known determinant of radiochemo-resistance. It has been shown that targeting focal adhesion proteins (FAPs), e.g. β1 integrin, enhances tumor cell radio(chemo)sensitivity in various entities such as head and neck squamous cell carcinoma (HNSCC), lung carcinoma, glioblastoma, …
Page 1 of 2